174 related articles for article (PubMed ID: 1656071)
1. An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.
Loudon RP; Moraska AF; Huber SA; Schwimmbeck P; Schultheiss P
J Virol; 1991 Nov; 65(11):5813-9. PubMed ID: 1656071
[TBL] [Abstract][Full Text] [Related]
2. Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.
Van Houten N; Bouchard PE; Moraska A; Huber SA
J Virol; 1991 Mar; 65(3):1286-90. PubMed ID: 1847455
[TBL] [Abstract][Full Text] [Related]
3. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis.
Huber SA; Moraska A; Choate M
J Virol; 1992 Nov; 66(11):6541-6. PubMed ID: 1328680
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte responses in CVB3-induced murine myocarditis.
Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor.
Huber SA; Mortensen A; Moulton G
J Virol; 1996 May; 70(5):3039-44. PubMed ID: 8627781
[TBL] [Abstract][Full Text] [Related]
6. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
Huber SA; Feldman AM; Sartini D
Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
[TBL] [Abstract][Full Text] [Related]
7. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes.
Guthrie M; Lodge PA; Huber SA
Cell Immunol; 1984 Oct; 88(2):558-67. PubMed ID: 6091924
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis.
Job LP; Lyden DC; Huber SA
Cell Immunol; 1986 Mar; 98(1):104-13. PubMed ID: 3017580
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis.
Huber SA; Graveline D; Born WK; O'Brien RL
J Virol; 2001 Jul; 75(13):5860-9. PubMed ID: 11390587
[TBL] [Abstract][Full Text] [Related]
10. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
Estrin M; Smith C; Huber S
Am J Pathol; 1986 Dec; 125(3):578-84. PubMed ID: 2432792
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
Weller AH; Simpson K; Herzum M; Van Houten N; Huber SA
J Immunol; 1989 Sep; 143(6):1843-50. PubMed ID: 2550544
[TBL] [Abstract][Full Text] [Related]
13. Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis.
Huber SA
Immunology; 2009 Aug; 127(4):567-76. PubMed ID: 19604307
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice.
Huber SA; Job LP
Adv Exp Med Biol; 1983; 161():491-508. PubMed ID: 6307010
[TBL] [Abstract][Full Text] [Related]
15. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells.
Huber SA; Sartini D; Exley M
J Virol; 2002 Nov; 76(21):10785-90. PubMed ID: 12368321
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring anti-idiotypic antibodies--mechanisms for autoimmunity and immunoregulation?
Weremeichik H; Moraska A; Herzum M; Weller A; Huber SA
Eur Heart J; 1991 Aug; 12 Suppl D():154-7. PubMed ID: 1655445
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.
Estrin M; Smith C; Huber S
Am J Pathol; 1986 Nov; 125(2):244-51. PubMed ID: 3024491
[TBL] [Abstract][Full Text] [Related]
18. Role of CD1d in coxsackievirus B3-induced myocarditis.
Huber S; Sartini D; Exley M
J Immunol; 2003 Mar; 170(6):3147-53. PubMed ID: 12626572
[TBL] [Abstract][Full Text] [Related]
19. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.
Huber SA; Job LP; Woodruff JF
Am J Pathol; 1980 Mar; 98(3):681-94. PubMed ID: 6244737
[TBL] [Abstract][Full Text] [Related]
20. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]